Inside the Pasqal Holding SA IPO: Setup, Risks, and Verdict
Pasqal Holding SA Ordinary Share is expected to list on NASDAQ on 2026-08-28 under ticker PSQL. The company has not disclosed a price range or share count yet. The setup leans on real commercial traction, but investors should watch valuation, dilution, and whether quantum demand can keep scaling.
Pasqal Holding SA Ordinary Share is expected to list on NASDAQ on 2026-08-28 under ticker PSQL. The company has not disclosed a price range or share count yet. The setup leans on real commercial traction, but investors should watch valuation, dilution, and whether quantum demand can keep scaling.
Quick Facts
Expected listing date: August 28, 2026
Exchange: NASDAQ
Proposed symbol: PSQL
Status: Expected
Company Overview
Pasqal is a quantum computing company focused on neutral-atom quantum computers. It builds and operates quantum processing units, or QPUs, and layers on a full software stack for industry, science, and government customers. Its systems are available on-premises and through the cloud, with applications in optimization, simulation, and AI / machine learning.
The company says it was founded in 2019 and is headquartered in France, with plans to establish a U.S. headquarters in Illinois at the Illinois Quantum and Microelectronics Park. Pasqal’s commercial platform spans QPU hardware, cloud access, software SDKs, hybrid quantum-classical integration, and services and support. It says it serves over 25 clients and partners across energy, financial services, materials science, and other sectors.
The broader market is still early, but the narrative is clear: quantum computing is moving from research toward commercial deployment, and Pasqal is pitching itself as a full-stack player in that transition. Its materials cite a $720 billion TAM by 2040 and emphasize hybrid quantum-classical computing, HPC integration, and room-temperature neutral-atom architecture that does not require cryogenics. The competitive field is crowded, with public names like IonQ, Rigetti, and D-Wave already fighting for mindshare and enterprise adoption.
Why They're Going Public
Pasqal says the capital raised, together with listing proceeds, will be used primarily in France to accelerate R&D, strengthen industrial capabilities and infrastructure, double production capacity within 24 months, hire about 50 new employees over 18 months, and develop an advanced fault-tolerant quantum computer by the end of the decade.
The business-combination materials also say the public listing should help expand QPU manufacturing and deployment, broaden cloud and software access, deepen integration with classical HPC, and scale commercial operations globally. In plain terms, the listing is meant to give Pasqal more balance-sheet flexibility to move from promising deployments to larger-scale commercialization.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
Pasqal’s commercial revenue rose to €16.5 million in 2025 from €3.5 million in 2024, which is roughly 371% year over year growth. That is a strong step-up for a company still in the early commercialization phase, and it shows the business is moving beyond pure R&D into paid deployments.
The company also said booked and awarded business including grants reached more than €66 million as of March 2026, with 25+ quantum solutions contracts and 10 commercial QPUs total, including 7 installed and 3 in production. On the profitability side, the company did not provide a clean quoted net income figure in the excerpts here, but it did say cash burn narrowed to €35.1 million in FY2025 from €50.0 million in FY2024. Total operating expenses were €76.1 million in 2025 versus €61.3 million in 2024. Cash disclosure was mixed across filings and presentations, including a €120.1 million current cash balance as of May 31, 2026, and approximately $360 million of cash available at closing after the business combination.
Risk Factors
The biggest risk is that Pasqal is still trying to prove that commercial momentum can scale fast enough to justify a public-market valuation. Quantum computing remains highly competitive globally, and Pasqal itself says competition could pressure pricing and gross margins. If customer adoption slows or enterprise budgets stay cautious, the revenue ramp could prove uneven.
There are also structural risks around regulation, dilution, and execution. Pasqal is subject to French foreign investment rules for sensitive sectors including quantum technology and defense, which can complicate strategic transactions. The company is still an emerging growth company, so disclosure is lighter than for mature public names. Lock-up terms also matter: insiders generally cannot sell until 180 days after closing, or earlier only if the stock trades at or above $12.00 for 20 of 30 trading days, which means the float could expand later and create pressure if the stock runs early.
Comparable Public Companies
The closest public comps are IonQ (IONQ), Rigetti Computing (RGTI), D-Wave Quantum (QBTS), and Quantum Computing Inc. (QUBT). IBM (IBM) is not a pure-play peer, but it matters as a strategic incumbent in the broader quantum ecosystem. Pasqal’s pitch is different from the smaller U.S. public names because it combines neutral-atom hardware, software, cloud access, and field deployments in one stack.
Relative to those peers, Pasqal is coming public with real revenue, a growing contract base, and a meaningful cash position, but it is still early in the commercialization curve. The company’s own materials frame it as one of the larger installed bases among pure-play quantum companies, though the market will still compare it against peers on revenue scale, burn rate, and how quickly it can convert bookings into repeatable sales.
The comp set remains mixed rather than uniformly hot. Quantum stocks have tended to trade on narrative, contract wins, and long-duration growth expectations more than near-term earnings power, so valuations can swing sharply. Without live market multiples in this run, the safest read is that the sector remains speculative and momentum-driven, with investors rewarding progress but still demanding proof of durable commercialization.
Verdict
This is a pre-pricing listing, so the main thing to watch is not a final verdict but the setup around valuation, float, and how much cash the transaction leaves Pasqal with at closing. The company has shown real commercial traction for an early-stage quantum name, but the market will want to see whether €16.5 million of 2025 revenue, €66 million+ of booked and awarded business, and 10 commercial QPUs are enough to support the next leg of growth without too much dilution.
The timing angle matters: this is not a broad IPO boom, but a selective public-market opening for quantum names that can show deployments and contracts rather than just research milestones. That makes Pasqal noteworthy right now. The setup favors investors who want exposure to the quantum commercialization theme, but shareholders should watch the disclosed pricing, the implied valuation versus peers, and whether the post-listing story is about execution or just long-dated promise.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
